ArticleBiomaterials and biosystems2026
Comparative analysis of different macromolecular crowding agents in human tenocyte cultures.
Article in Biomaterials and biosystems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tendon engineered substitutes remain clinically unavailable, largely due to the need for prolonged culture periods to allow for sufficient extracellular matrix deposition. Although macromolecular crowding allows for accelerated extracellular matrix deposition, the optimal macromolecular crowding agent in human tenocyte cultures is still unknown. Here, we measured the physicochemical properties of six macromolecules (κλ carrageenan, λ carrageenan, polysucrose, polyacrylic acid, hyaluronic acid and polyvinylpyrrolidone) and assessed their effect in human tenocyte basic function, collagen type I deposition and gene expression. The κλ carrageenan exhibited the highest polydispersity index. None of the macromolecules impaired cell viability and metabolic activity. The κλ carrageenan and the λ carrageenan significantly enhanced collagen type I deposition. A macromolecular crowding agent dependent gene expression was observed, with the κλ carrageenan appearing to induce a more mature phenotype. This study provides a framework for selecting an appropriate macromolecular crowding agent to enhance and accelerate extracellular matrix deposition, whilst maintaining acceptable cell function.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.